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ABSTRACT 
 
CIGARETTE SMOKE PROMOTES GENOMIC EVOLUTION 
IN THE PERIODONTAL PATHOGEN 
PORPHYROMONAS GINGIVALIS 
        Josh George 
        04/26/2013 
 
 P. gingivalis is an opportunistic, anaerobic, Gram-negative oral pathogen strongly 
implicated in the pathogenesis of periodontal diseases. Clinical isolates of P. gingivalis 
exhibit great genetic diversity. Tobacco smoking greatly increases the risk of P. 
gingivalis infection.  Furthermore, cigarette smoke extract (CSE) is an environmental 
stressor for P. gingivalis, differentially regulating multiple genes including ones that 
encode proteins involved in DNA translocation, replication and repair.  Therefore, we 
hypothesized that CSE exposure would promote genomic instability in this important 
periodontal and systemic pathogen, which may contribute to increased virulence.  
P. gingivalis W83 was passaged 50 times in CSE-conditioned medium after 
which, genomic DNA was extracted and whole-genome sequencing was employed to 
identify any chromosomal alterations induced by CSE compared to un-exposed controls. 
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Whole genome sequencing identified 22 CSE-induced point mutations (p<0.05), 
17 or which were confirmed as well as significant allelic variance (p<0.001) in CSE 
versus control samples.  Our results indicate that CSE exposure promotes genetic 
diversity in a laboratory strain of P. gingivalis. Should this phenomenon occur in vivo, 
tobacco smoke could promote bacterial evolution and, thus, contribute to the emergence 
of more virulent strains in this key periodontal pathogen, which may infect smokers and 
non-smokers alike. 
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CHAPTER ONE: INTRODUCTION AND LITERATURE REVIEW 
 
The use of smoking tobacco is one of the most major and preventable causes of 
premature mortality across the world [1,30].  Cigarette smoking and exposure to smoke is 
associated with chronic diseases, economic losses to society, and a substantial burden on 
the United States healthcare system, costing billions of dollars annually [1,2].  
From the years 2000-2004, it is estimated in the United States that cigarette 
smoking and cigarette smoke exposure resulted in 443,000 premature deaths, 5.1 million 
years of potential life lost, and $96.8 billion in productivity losses annually [1]. One 
study estimated nearly 25 percent of all deaths in the age group 35-69 are directly 
attributed to smoking [30].  Studies have also implicated smoking as the primary causal 
factor for at least 30 percent of all cancer deaths as well as 80 percent of all deaths from 
chronic obstructive pulmonary disease and early-onset cardiovascular diseases [1]. 
Approximately one-third of the adult global population are tobacco users and 5-6 
million people die annually due to tobacco-related illnesses [4]. While the use of smoking 
tobacco has declined in the United States in recent decades [30], global use has increased 
in developing nations [10]. Nearly 80 percent of annual tobacco related deaths occur in 
middle- to low-income countries [3].   
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Tobacco Smoke Toxicity 
 
The serious ramifications of tobacco use come in the form of smoking related 
diseases. Tobacco smoke puts users at increased risk for a wide range of diseases such as; 
cardiovascular disease, oral, airway, and lung diseases, numerous cancers, immune 
disorders, persistent infections, and numerous chronic inflammatory diseases [6,14,16, 
28].  
Increased health risks are directly attributed to the high toxicity of tobacco smoke.  
The gaseous and particulate phases of cigarette smoke contain more than 4,500 chemicals 
which include 70 known carcinogens, as well as other reactive solids, oxidative species 
(free radicals), and mutagenic components [5-7]. Some of the more hazardous 
components of tobacco smoke include; ammonia, carbon monoxide, carbon dioxide, 
formaldehyde, acrolein, acetone, benzopyrenes, and hydroxyquinone as well as heavy 
metals including cadmium and arsenic [5,6].  
 Smoking tobacco accounts for up to 85 percent of global tobacco production and 
use, and is the most hazardous form of tobacco use as observed by the more severe and 
diverse types of diseases when compared to smokeless tobacco [8].  
Active smokers are not the only individuals at risk for adverse side effects from 
tobacco smoke.  Cigarette smoke is a major environmental pollutant and exposure to 
second hand smoke has been linked to susceptibility to many of the same diseases 
associated with active smoking in both adults and children [9,11,12,17] 
The causticity of tobacco smoke and its status as a ubiquitous environmental 
pollutant directly contribute to the global disease burden via its mutagenic capacity 
(explained in later section) as well as multiple adverse effects on the innate and adaptive 
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immune systems, greatly increasing the risk of chronic infectious and inflammatory 
diseases [5,13,15-22] as will be discussed in the following sections. 
 
Tobacco Smoke and Chronic Inflammatory Diseases 
 
Tobacco smoke puts users at an increased risk for developing chronic 
inflammatory diseases.  While the mechanisms are not fully understood, studies have 
associated smoking with inflammatory conditions such as acute vascular diseases [14,42], 
inflammatory bowel disorders [6,21] renal disease [19], pancreatitis [20] and periodontal 
diseases [41].  Studies also show smoke can deregulate endocrine and immune systems, 
predisposing users to autoimmune inflammatory disorders such as primary biliary disease 
(PBD), rheumatoid arthritis (RA), and multiple sclerosis (MS)  [22,43,44].  
Evidence has shown tobacco smoke deregulates and increases the expression of 
several systemic pro-inflammatory markers indicated in chronic inflammation such as 
elevated levels of serum fibrinogen and plasma C-reactive proteins, as well as pro-
inflammatory cytokines and chemokines, which in turn leads to increased levels of 
macrophages, monocytes, and neutrophils [44].  
For example, smoke-induced stress on blood vessels increases vascular 
permeability and activates increased adhesion molecule expression, resulting in increased 
leukocyte adhesion and platelet aggregation eventually leading to atherosclerotic lesions 
and thrombus formations greatly increasing the risk of heart attack and/or stroke 
[14,42,48,49]. 
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 Pulmonary dysfunction and chronic inflammation of the airways such as 
emphysema and chronic obstructive pulmonary disorder (COPD) are also elicited by 
tobacco smoke [47].  Smoke exposure on airway epithelia increases pro-inflammatory 
cytokine expression, induces rapid influx of activated neutrophils and macrophages and 
formation of free radicals, as well as release of degradative enzymes such as neutrophilic 
elastase and matrix metalloproteases (MMPs) [40]. 
 
Tobacco Smoke and Infectious Diseases 
 
Smokers as well as those exposed to environmental (second-hand) smoke are 
more susceptible to contracting infectious diseases than non-smokers, such as respiratory 
tract infections, pneumonia, tuberculosis, meningitis, bacterial sexually transmitted 
diseases, and periodontal diseases to name only a few [17,25].  While there is a robust 
amount of evidence correlating the effects of smoking adversely affecting human health, 
there is a gap in knowledge, mechanistically to explain such phenomena [102].   
It has been hypothesized that smoking increases the risk of infection by three 
general mechanisms: tobacco-induced host physiological and structural changes, 
deregulation of innate and adaptive immune systems, and increasing bacterial virulence 
[17].  There is much evidence to support this hypothesis.  
Cigarette smoke components and their metabolites such as acrolein, acetaldehyde, 
formaldehyde, and free radicals are implicated in contributing to structural changes 
observed in the respiratory tract, aiding bacterial colonization and infection [100,101]. 
Such changes include peribronchiolar inflammation and fibrosis, increased mucosal 
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permeability and impairment of the mucociliary clearance. These structural changes 
decrease the ability of the host to clear pathogens from the airways, aiding bacterial 
colonization and infection [103].   
Various structural changes can also be induced by cigarette smoke [17].  Clinical 
evidence has shown cigarette smoke exposure causes cerebral vessels to dilate [95], while 
causing peripheral arterial vessels constrict [46].  In the periodontal tissues, cigarette 
smoke has been shown to suppress angiogenesis [57].  
Cigarette smoke is also highly implicated in deregulating the innate immune 
system.  Studies have shown tobacco smoke to decrease phagocytic activity and 
generation of reactive-oxygen species in neutrophils and monocytes, suppressing their 
responsiveness and bacterial-killing capacity, and consequently aiding pathogenic 
colonization and infection [104-106].  Tobacco smoke also reduced dendritic cell 
antigen-presenting and co-stimulatory molecules, and reduced capacity for antigen uptake 
and production of T-cell stimulatory cytokines in murine models [107].  
Adaptive immunity is also compromised upon exposure to tobacco smoke.  
Reduced serum levels of Immunoglobulin G (IgG), an important anti-microbial antibody, 
have been detected in smokers when compared to non-smokers [96,97].  T-cell 
proliferative responses have also shown to be suppressed in smokers.  Studies have 
shown a decrease in the ratio of CD4 to CD8 lymphocytes in heavy smokers.  This is 
explained by a decrease in CD4 lymphocytes while there is a simultaneous increase in 
CD8 lymphocytes [98,99].  Because CD4 lymphocytes stimulate B-cell proliferation and 
differentiation as well as immunoglobulin synthesis, the decrease of CD4 lymphocytes in 
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heavy smokers may be a possible explanation for the observed reduced serum IgG levels 
in smokers [25]. 
Smoke may also induce increased bacterial virulence, contributing to increased 
susceptibility of infection [17].  For example, smoke exposure induced increased 
adhesion of respiratory pathogens to airway epithelial cells in smokers [108].  Smoke can 
also induce shifts in microbial populations allowing pathogens to proliferate [109].  
While there is still much research that needs to be conducted on the subject, there is 
convincing evidence that tobacco smoke can both genotypically and/or phenotypically 
alter pathogens and increase virulence. The effects of tobacco-induced alterations on the 
genome, physiology, and virulence of the periodontal pathogen Porphyromonas 
gingivalis will be discussed in detail in later sections. 
 
Periodontal Diseases  
 
Periodontal diseases are both infectious and inflammatory. Data from the World 
Health Organization suggests that 5-20 percent of the adult global population suffers 
from severe periodontitis and that most children and adolescents will exhibit signs of 
gingivitis at some point in their lifetime [130].  A study using data from 
the 2009 and 2010 National Health and Nutrition Examination Survey (NHANES) 
estimated the prevalence, severity, and extent of periodontitis in the adult U.S. 
population.  The results indicated that roughly 47 percent adults aged 30 years or older, 
had periodontitis, distributed as 8.7 percent, 30 percent, and 8.5 percent with mild, 
moderate, and severe periodontitis, respectively. For adults aged 65 and older, 64 percent 
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had either moderate or severe periodontitis. This survey provides direct evidence of the 
high burden of periodontitis in the United States [34].  
Bacteria in the oral cavity often proliferate in an attached multispecies biofilm 
community, commonly known as dental plaque. The composition of the microbiota in 
biofilms can be altered due to factors such as diet, host genotype, antibiotic ingestion, 
pathogen infection, and other environmental effects, which can greatly affect host 
physiology, metabolism, and immune systems [117]. Periodontal disease and the 
resulting inflammation is caused when Gram negative oral pathogens such as P. 
gingivalis, Treponema denticola, and Tannerella forsynthia invade the gingival sulcus 
between the junctional epithelium below the gingival margin and the clinical root of the 
tooth, altering the commensal biofilm composition, and challenging the host immune 
system [24,50] as shown in Figure 1. Subgingival colonization by these periodontal 
pathogens is aided by the expression of several immune subverting virulence factors, 
which will be discussed in a later section. 
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Figure 1 shows what occurs during periodontal disease - accumulation of 
pathogenic bacteria and biofilm formation that develops in the subgingival pocket.  The 
release of multiple pro-inflammatory cytokines (IL-1, TNF, IL-6, etc) are detectable and 
are expressed in the gingival tissue as well as released into the gingival crevicular fluid 
activating neutrophils, macrophages, and recruiting them to the site of infection 
eventually leading to connective tissue matrix degradation and osteoclast activation 
which leads to the degradation of bone.   
There are progressive stages of periodontal disease that are characterized by the 
severity of hard and soft periodontal tissue damage, such as bleeding on probing, pocket 
depth, and gingival and alveolar bone resorption.  Gingivitis is the initial stage of 
periodontal disease and is characterized by minor redness, swelling, and bleeding on 
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probing.  The minor inflammation of gingivitis is reversible and does not cause any 
lasting or permanent damage [27].  However, if left untreated, gingivitis can progress into 
the more severe form of periodontal disease, periodontitis.  Periodontitis is characterized 
by irreversible inflammatory damage of the periodontal tissues such as detachment of the 
periodontal ligament, gingival resorption, and alveolar bone loss, eroding the supporting 
structures of the teeth resulting in tooth mortality and tooth loss over time [23, 24].   
The severity and progression of the inflammatory immune response varies 
depending on host-specific factors.  Things such as age, race, and immune abnormalities 
are just a few of the important factors that affect the host immuno-inflammatory response 
[29].  
The colonization of the sub-gingival pocket by Gram-negative periodontal 
pathogens stimulates secretion of pro-inflammatory cytokines such as IL-1, IL-6, IL-8, 
TNF and RANKL from host oral epithelial cells [51] as shown in Figure 1.  Pro-
inflammatory cytokine secretion causes immediate swelling and redness of the 
periodontal tissues. Inflammation becomes more severe as pathogens proliferate 
promoting further, possible permanent tissue damage [23, 24, 27].  
Bacterial persistence and prolonged cytokine secretion activate osteoclasts in the 
host alveolar bone [37].  When osteoclasts become activated, bone matrix is broken down 
causing irreversible bone resorption from the alveolar crest. If left untreated, bone loss 
will continue apically toward of the root of the tooth [31].  The destruction of the 
supporting tooth structure consequently causes loss of attachment resulting in tooth 
mobility and eventual loss of the tooth [23,24]. 
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Tobacco Smoke and Periodontal Disease 
 
Tobacco smoke is a major environmental pollutant and significant risk factor for 
periodontitis. Accordingly, smokers have a high predisposition of developing plaque-
induced periodontal diseases and consequently a higher prevalence [29,32,33].  Tobacco 
smoke is a major risk factor for periodontal disease because the oral cavity is the 
entryway for smoke into the airways and therefore naturally has the highest concentration 
of smoke components, especially in the gingival crevicular fluid (GCF) excreted from the 
gingival sulcus [93].  
Evidence suggest high concentrations of tobacco smoke components induces a 
shift in periodontal plaque composition from one that is mainly constituted of Gram 
positive, aerobic, commensal bacteria to one that contains more Gram negative, anaerobic 
pathogens, such as P. gingivalis [50].   
Studies show a clear dose-dependent relationship between smoking and 
periodontal disease [35].  High levels of tobacco smoke inhalation are associated with 
faster disease progression and more severe periodontal damage.  Clinical evidence shows 
increased gingival recession and alveolar bone loss, greater periodontal ligament (PDL) 
attachment loss and deeper gingival pocket formation that is responsible for increased 
tooth mobility and tooth loss at an earlier age than non-smokers [36,37].  It has also been 
shown that patients who suffer from periodontal disease are much more likely to be 
refractory to treatment if they are active smokers, when compared against non-smokers 
[36].  
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Various studies have been conducted which give insight into the link between 
tobacco smoke and periodontal disease.  Nicotine, a major smoke component has been 
shown to induce periodontal collagen degradation by increasing expression of the 
collagenase matrix metalloproteases (MMPs), which may result in detachment of the 
periodontal ligaments [54]. Several studies have also indicated nicotine and one of its 
major metabolites cotinine, adversely affect human periodontal fibroblasts (PDFs) 
decreasing their levels of attachment, proliferation, and chemotactic responsiveness in a 
dose-dependent manner [39, 52].  One study shows, upon exposure to nicotine stress 
periodontal fibroblasts increase c-fos expression, to protect against cellular damage [55].  
This same study suggests that the nicotine-dependent stress-specific expression of the c-
fos gene correlates with cellular thiol levels in human PDFs. Thiols are exceedingly 
important in that they act as an antioxidant defense system to protect the cell against 
oxidative damage.   
 Acrolein is another pernicious smoke component and major player in the 
destruction of periodontal tissues.  In a study conducted by Chang et al. [55], it was 
shown that acrolein significantly depleted intracellular thiol levels in PDFs. Therefore, 
decreased levels of thiol make the PDFs much more susceptible to damage by oxidants 
contained in tobacco smoke. The same study also showed that acrolein can suppress PDF 
proliferation by as much as fifty percent, resulting in significant attachment loss of the 
periodontal ligaments.  
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Tobacco Smoke and Periodontal Inflammation 
 
Despite being more susceptible to periodontitis and exhibiting faster disease 
progression and severity, chronic smokers lack the clinically overt inflammatory response 
to bacterial plaque that non-smokers exhibit such as redness, swelling, bleeding on 
probing and reduced pro-inflammatory indicators [56].  As discussed in previous 
sections, tobacco smoke is a major environmental toxin and as such, has the ability to 
alter the user’s inflammatory responses by deregulating the innate and adaptive immune 
systems.  
Evidence suggests that tobacco smoke deregulates important sequential adhesion 
molecule cascades that are critically important for leukocyte recruitment and causes 
inappropriate leukocyte activation [57]. Therefore, normal inflammatory reactions may 
be compromised.  Cigarette smoke also induces local suppression of angiogenesis, 
providing a possible explanation for reduced amounts of bleeding [56, 58].  
All of these observations make it apparent that tobacco smoke plays an important 
role in the pathogenesis and severity of periodontal disease. However, the mechanisms by 
which tobacco smoke masks periodontal inflammation warrants further investigation 
[56].  Much of the research on the matter has been directed towards the host response to 
smoking and periodontal infection.  However, it is poorly understood how tobacco smoke 
affects periodontal pathogens and what affect this has on their virulence in pathogens 
such as P. gingivalis. 
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Porphyromonas gingivalis 
 
Porphyromonas gingivalis is an opportunistic, Gram-negative, assacharolytic, 
anaerobic oral pathogen highly implicated in the pathogenesis of periodontitis and 
systemic sequelae.  Socransky et al. 1998 characterized periodontal microbial 
communities based on cluster analysis, community ordination and associated disease 
severity.  The periodontal bacteria were then categorized into five separate color-based 
complexes which increase in severity of disease association in the following order; 
purple, yellow, green, orange, and red.  P. gingivalis is a member of the “red complex” 
which also includes T. denticola and T. forsythia.  
Numerous studies have detected these three oral pathogens as being strongly 
associated with each other and with severe disease sites [66].  Due to the ease of growth 
and ability to be genetically manipulated, P. gingivalis has become the most well studied 
out of the three oral bacteria in the red complex [74]. 
Further analysis of P. gingivalis has led to its designation as a keystone pathogen.  
A validated murine model study [112] provides evidence that P. gingivalis, even at low 
abundance has the ability to significantly induce alterations to host commensal 
microbiota in a way supports its own viability while promoting disease pathogenesis.  In 
these models, specific pathogen free (SPF) mice inoculated with P. gingivalis caused 
significant bone loss which is a defining characteristic of periodontal disease. In contrast, 
germ free (GF) mice inoculated with a P. gingivalis mono-infection saw no significant 
bone loss indicating that P. gingivalis alone cannot induce periodontitis.  This study 
indicates that rather than directly attacking host periodontal tissues, P. gingivalis 
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contributes to disease indirectly by significantly altering the total commensal microbial 
load and biofilm composition, which overwhelms normal host tissue-protective 
mechanisms and homeostasis, resulting in an immune-inflammatory response, promoting 
disease pathogenesis. 
 
P. gingivalis Genome  
 
 Nelson et al. [110], sequenced the complete 2,343,479-bp genome of P. gingivalis 
strain W83, a highly virulent strain used in experiments conducted for this thesis. The 
W83 genome contains 2,015 genes, encoding 1,990 and has an average G/C content of 
48.3%. There are four ribosomal operons and two structural RNA genes, as well as 53 
tRNA genes with specificity for all 20 amino acids.  Analysis revealed a total of 1,990 
open reading frames (ORFs) approximately 85% of the genome.  Of these ORFs, 1,075 
were assigned biological roles, 184 were conserved hypothetical proteins or conserved 
domain proteins, 208 had unknown functions, and 523 encoded hypothetical proteins.   
Repetitive elements were revealed including DNA repeats {direct repeats and 
clustered regularly interspaced short palindromic repeats (CRISPRs)} as well as 
transposable elements {Insertion sequences (ISPg1-11) and miniature inverted-repeat 
transposable elements (MITE239, MITE464, MITE700)}.  Repetitive and transposable 
elements occupy approximately 6% of the genome. It was revealed that 96 complete or 
partial copies of IS elements are present within the genome.  However, it was indicated 
they are rarely found in functional genes and instead are inserted almost exclusively into 
intergenetic regions (IGRs) and other copies of transposable elements.  
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Further analysis indicated 21 areas of the genome that displayed atypical 
nucleotide composition based on increased and/or decreased levels of G/C content when 
compared to the rest of the genome.  The investigators believed a variety of genes could 
possibly have been acquired through lateral gene transfer and are encoded in these 
regions. These genes include restriction system proteins, hemagglutinin proteins B and C, 
numerous capsular biosynthesis proteins, 20 transposase genes, and two large mobile 
elements.  
 
Clinical P. gingivalis Strain Variants 
 
Genotypic characterization of P. gingivalis strains has revealed extensive genetic 
variability [72].  A study by Griffen et al. [114], used heteroduplex analysis of the 
ribosomal internal spacer region (ISR) between 16S and 23S ribosomal genes of P. 
gingivalis to detect strain variants as well as determine if all strains exhibit similar 
strengths of association with periodontal disease or rather if there are more- and less- 
virulent strains.  P. gingivalis samples were collected from patients with clear indicators 
of periodontal disease as well as age-matched, healthy, control patients.  Analysis 
revealed eleven P. gingivalis heteroduplex types, of which six types had sufficient 
numbers for statistical analysis.  It was determined type hW83 was the most strongly 
associated with periodontal disease.  Additionally, types h49417 and hHG1691 were also 
significantly associated with periodontitis but with lower odds ratios than hW83.  The 
remaining three types h23A4, h381, and hA7A1 were not significantly associated with 
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disease pathogenesis.  The results of these analyses indicate there are in fact differences 
in virulence between clinical strains of P. gingivalis. 
A more recent study conducted by Igboin et al. [113] confirmed the previous 
study’s findings as well as used ISR heteroduplex analysis to determine worldwide 
genetic variability and distribution of P. gingivalis.  In this study, samples were taken 
from patients at 3 U.S locations (Columbus, Ohio/San Antonio, Texas/San Francisco, 
California) as well as from foreign college students entering the U.S. who had arrived no 
more than 30 days prior to taking plaque samples.  Heteroduplex analysis confirmed the 
six predominant heteroduplex types {W83 (including strain W50), 23A4, A7A1, 381 
(including strain ATCC 33277), HG1691, and ATCC49417} of the previous study in all 
U.S. locations as well as foreign continents, with 14 rare heteroduplex types showing up 
in only one or a few locations.   
Furthermore, investigators used microarray-based comparative genomic 
hybridization (CGH) to analyze whole genome variability of the major heteroduplex 
strains. Using strain W83 as the control, it was found that the control genome was highly 
conserved among the major heteroduplex types ranging between 0% variability when 
compared with strain W50 to 5.1% when compared to strain ATCC 33277.  Both ISR and 
CGH revealed strains ATCC 49417 and W50 to be very closely related to strain W83, 
respectively. 
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P. gingivalis and Periodontal Disease 
  
 Studies have shown more than 700 species of bacteria can colonize the oral 
cavity, while only a small number are associated with disease [65].  Of these, P. 
gingivalis is strongly implicated in the development and progression of periodontal 
disease. It is widely believed that polymicrobial interactions within dental plaques are 
may be responsible for the initiation and progression of inflammatory periodontal 
diseases [119]. Unfavorable alterations in periodontal biofilm communities, such as 
pathogenic outgrowth of a keystone species like P. gingivalis, deregulate host 
homeostasis [112,121-122]. P. gingivalis exhibits aggregative properties and several 
virulence factors which aid in colonization and tissue destruction such as fimbriae, 
proteases, lipopolysaccharides, and capsular polysaccharides [119].  Based on these 
properties and clinical observations, P. gingivalis is considered an opportunistic pathogen 
that is significantly associated with periodontal disease [65].   It is often isolated from 
plaque biofilms removed from tooth surfaces in individuals with periodontal disease (79-
90%) while rarely found in healthy individuals (10-25%) [113].  
Several studies have linked the association of P. gingivalis with periodontal 
disease.  P. gingivalis has been positively correlated with gingival pocket depth formation 
in humans indicating there is an approximate 10-fold increase of P. gingivalis cells per 1-
millimeter of increased pocket depth in diseased sites [116].  A review of several animal 
studies revealed P. gingivalis induced inflammatory immune responses and periodontal 
bone loss in these models [120].  It has also been shown that reducing the numbers of P. 
gingivalis cells via clinical scaling and root planing reduced clinical symptoms of 
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periodontal disease such as gingival redness, bleeding on probing, and pocket depth 
[123]. 
 
P. gingivalis Invasion, Proliferation, and Virulence 
 
P. gingivalis Invasion and Proliferation 
P. gingivalis has the ability to invade host periodontal tissues while evading host 
defenses.  In doing so, it causes deregulation of the host immuno-inflammatory responses 
[50].  The following sections will discuss the invasiveness of P.  gingivalis and its ability 
to evade host defenses as well as the role of its major virulence factors including the 
capsule, gingipains, fimbriae, and lipopolysaccharides (LPS). 
P. gingivalis is able to actively invade host cells such as human gingival epithelial 
cells, where it can avoid immune surveillance, replicate, and stay viable within the host 
cell [62,67].  P. gingivalis also has the ability to invade macrophages, but does not 
replicate as frequently as within other cells [64].  P. gingivalis uses its major fimbriae to 
invade host cells. These major fimbriae bind with host cell-surface β1 integrins where P. 
gingivalis can then rearrange the host cell’s cytoskeleton allowing it to internalize and 
move from cell to cell via cytoskeleton bridges [63].  Evidence has shown that P. 
gingivalis remains viable within host cells as there is no evidence of necrosis or 
apoptosis.  P. gingivalis has the ability inhibit gingival epithelial cell apoptosis induced - 
by ATP ligation of P2X7 receptors. This is accomplished through secretion of an ATP-
hydrolyzing enzyme, suppressing host cell ATP-dependent apoptosis [62]. The ability of 
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P. gingivalis to internalize itself in host cells and remain viable while subverting immune 
surveillance greatly influences its survival and proliferation in the periodontal pocket.   
 
P. gingivalis Capsule 
 Strains of P. gingivalis are very heterogeneous and some of these strains, 
including W83, produce an extracellular capsular polysaccharide (CPS), also known as 
its K-antigen or serotype.  There are at least six different known serotypes, which are 
characterized by the capsules ability to generate systemic IgG antibody responses.   
Encapsulated strains of P. gingivalis are shown to be highly invasive, while being 
able to evade the host pro-inflammatory immune response [50].  In murine models, 
encapsulated strains of P. gingivalis were associated with increased abscess formation 
and spreading infection when compared to non-encapsulated strains, which only induced 
localized abscesses [68]. 
In a study by Brunner et al. [61], the role of the P. gingivalis W83 capsule in 
evading the innate immune response was studied. An espC gene-knockout mutant was 
constructed for P. gingivalis W83; espC is located at the end of the capsular synthesis 
locus inhibiting formation of the capsule.  The wild-type strain and the espC mutant 
challenged human gingival fibroblasts (HGFs) and the expressions of IL-1β, IL-6, and 
IL-8 transcription levels were measured.  Results indicated high cytokine and chemokine 
transcription levels were found when the HGFs were challenged with the espC knockout 
than with the wild-type strain.  This evidence suggests that the capsule may help mask P. 
gingivalis from the host pro-inflammatory immune response, helping to promote 
virulence. 
  20 
Such a mechanism is especially important in the case of infectious chronic 
inflammatory diseases such as periodontal disease in which evading the host immune 
response helps P. gingivalis proliferate and persist while avoiding immune clearance 
[59].  However, the potential involvement of the capsule in the overall deregulation of the 
host response needs further study [50]. 
 
P. gingivalis Proteases (gingipains) 
 P. gingivalis produces trypsin-like cell surface cysteine proteinases, also known 
as gingipains. Gingipains can account for up to 85% of the proteolytic activity of P. 
gingivalis.  Based on substrate specificity, they are divided into arginine-specific (Arg-X) 
and lysine-specific (Lys-X) gingipains coded by the rgpA, rgpB, and kgp genes, 
respectively [69]. 
 Gingipains play an important role in the virulence of P. gingivalis while also 
deregulating the host immuno-inflammatory response.  Gingipains are capable of 
cleaving T-cell receptors such as CD4 and CD8, thereby greatly inhibiting cell-mediated 
immunity [71].  They also have the ability to degrade cytokines and complement pathway 
proteins conceding increased resistance to bacterial clearance from the host immune 
response [50]. 
 Aside from evading immune surveillance, gingipains may be directly involved in 
the ability of P. gingivalis to invade host cells. Evidence has shown rgp to mediate P. 
gingivalis adherence to oral epithelial cells.  Evidence also shows once P. gingivalis has 
invaded the host cell, expression of gingipains is reduced [70]. 
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 Gingipains may also affect vascular permeability and the blood coagulation 
system causing increased bleeding at the periodontal site perpetuating inflammation and 
gingival edema [50]. 
 
P. gingivalis Fimbriae 
The major fimbriae of P. gingivalis are thin, hair-like filamentous cell-surface 
structures encoded by the fimA BCDE operon.  P. gingivalis fimbriae facilitate its ability 
to adhere to salivary proteins, extracellular matrix, oral epithelial cells, and bacteria of the 
same or other species. Through its fimbriae, P. gingivalis can adhere itself to early 
colonizing bacteria, and participate in the developing biofilm structure making it essential 
for invading and colonizing the host [74].  
There are both major and minor fimbriae.  Studies show major fimbriae play an 
important role in colonization and invasion, while minor fimbriae are indicated in 
activating the host inflammatory response [50].  Based on genomic variations of the fimA 
gene, major fimbriae have been classified into six types (Type I-V, Ib) [73,74].  Minor 
fimbriae are encoded from the mfa gene (mfa1, mfa2) [78]. Type II, major fimbriae is 
found to be the most virulent and commonly associated with severe periodontal disease 
[75].   
Alveolar bone resorption is a hallmark of periodontitis.  Murine models of 
periodontitis directly indicate P. gingivalis major (type II) and minor (mfa1) fimbriae in 
the induction of alveolar bone destruction [77].  Other characteristics of major and minor 
fimbriae are the capacity to evoke a pro-inflammatory cytokine response (IL-1, IL-6, IL-
8, and TNF- α) from various host cells as well as expression of matrix metalloproteases 
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[50].  Major fimbriae induce increased expression of adhesion molecules from host oral 
epithelial cells promoting further adhesion and invasion of host cells by P. gingivalis 
[79].  P. gingivalis fimbriae have also proven to be an important virulence factor for 
survival, interacting with complement receptor 3 (CR3) inhibiting IL-12 secretion from 
host immune cells increasing resistance against immune clearance [76].  
 
P. gingivalis Lipopolysaccharide (LPS) 
Toll-like receptors (TLRs) play a pivotal role in initiating host immune responses 
and are implicated to be involved in the development of many infectious diseases, such as 
periodontitis [80].  P. gingivalis LPS is a key inflammatory mediator.  Studies have 
shown P. gingivalis LPS to be recognized by TLR2 and TLR9, while there is debate over 
TLR4 recognition [80,81]. P. gingivalis LPS stimulates pro-inflammatory cytokine 
secretion from host immune and oral epithelial cells, including IL-1, IL-6, IL-8, IL-18, 
and TNF-α [50].  It is also implicated in alveolar bone loss [82], as well as increasing risk 
the risk of systemic disease such as atherosclerosis [83]. 
 P. gingivalis LPS is a weaker inducer of inflammation and pro-inflammatory 
cytokine secretion than LPS of other Gram-negative bacteria, such as Escherichia coli 
[84].  While most gram-negative LPS’s are strong TLR4 inducers, P. gingivalis LPS 
primarily activates TLR2 and may even serve as an antagonist to TLR4 [85,86].  
Evidence indicates this is due to structural LPS heterogeneity found within the acylation 
patterns of the lipid A portion of P. gingivalis LPS.  There are two known forms of P. 
gingivalis LPS lipid A - penta-acylated and tetra-acylated.  Studies show penta-acylated 
lipid A acts as an agonist on TLR4, while tetra-acylated lipid A acts antagonistically 
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against TLR4, modulating the host immune response [85, 87].  Variations in acyl chain 
length have also shown to alter host immuno-inflammatory activity [88].  These 
alterations to the lipid A portion of P. gingivalis LPS, as well as the host immune 
response can be strain specific or environmentally induced by things such as hemin 
concentration [88,89]. 
 
Tobacco Smoke and Bacterial Genomic Stability 
 
A study conducted by Aufderheide et al. [90] examined the bacterial mutagenic 
and cytotoxic capabilities of cigarette mainstream whole smoke and its gas/vapor phase 
using a modified Ames assay (bacterial reverse mutation assay).  Standard S. 
typhimurium bacterial tester strains were used: TA98, TA100, TA1535, TA1537, 
TA1538, TA102, as well as descendant strains of TA98 (YG1021, YG1024, YG1041) 
and TA00 (YG1026, YG1029, YG1042).  WP2uvrApKM101, an E. coli strain, was also 
used. 
The mutagenicity of WS smoke was detected using (TA1538) TA98, (TA1535) 
TA100 strains and their YG descendants as well as WP2uvrApKM101 in the presence of 
S9 mix (metabolic activating system) and the plasmid pKM101, requiring a frame-shift 
mutation.  To detect mutagenicity in GVP, TA100 and descendent strains as well as 
WP2uvrApKM101 were used in the presence of the pKM101 plasmid and the absence of 
S9 mix, requiring a missense mutation. Based on the addition of S9 mix to WS analysis, 
investigators implicated that many of the components need to be metabolized before 
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exerting mutagenic activity. Oppositely, the absence of S9 in the GVP analysis indicates 
many of the mutagenic components are direct acting. 
The results of WS analysis revealed that all strains showed genetic mutations 
(induction of revertants).  Mutagenic activity increased in a dose-dependent manner to a 
maximum point that varied among different strains after which point the WS induced 
toxic effects.  GVP analysis also revealed genetic mutations.  Missense mutations were 
detected in WP2uvrApKM101 as well as strains TA1538, TA100 and its YG descendants 
apart from YG1026.   
Further analysis using several brands of cigarettes revealed that increased levels 
of tar increased the mutagenic capacity of the cigarette smoke in most cases. Investigators 
determined that tar content alone is not solely responsible for increased mutation.  Rather, 
the composition of the tar such as different types of tobacco, nitrate levels, etc. as well as 
cigarette components and function such as filters and ventilation are responsible for 
mutagenic capacity [90].  These findings are in line with previous studies [91,92] 
conducted to determine the mutagenic capabilities of cigarette smoke. 
The effects of tobacco smoke on the genomic stability and virulence of the 
periodontal pathogen P. gingivalis is explained in the following sections. 
 
Tobacco Smoke and P. gingivalis Genome, Physiology, and Virulence 
 
P. gingivalis Genome and Physiology 
The previous sections have discussed the toxicity of tobacco smoke and the 
impact tobacco smoke has on deregulating host immuno-inflammatory responses to 
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bacterial infections such as periodontal disease.  However, little is known about the 
effects tobacco smoke has on bacterial physiology and genomic stability and the role it 
plays in disease pathogenesis, such as with the periodontal pathogen P. gingivalis. 
 A study by Bagaitkar et al. [115] investigated the effects of cigarette smoke 
extract (CSE) on gene expression in P. gingivalis.  Using microarray analysis, it was 
discovered that 6.8% of the P. gingivalis genome was differentially expressed upon 
exposure to CSE.  A total of 104 genes were significantly differentially expressed by a 
minimum of two-fold or greater.  Of which, CSE induced expression of 58 genes while 
suppressing 46.  
Analysis revealed many of the genes induced by CSE had known or putative 
functions, several of which were located within operons or were functionally related. Of 
the 58 genes induced by CSE, two genes were identified in the major fimbrial operon, as 
well as an operon encoding outer-membrane antigenic lipoproteins.  Groups of 
functionally related genes were also identified such as in DNA replication and repair 
genes (ruvC, radC, and a putative integrase), genetic insertions and transpositions (traE, 
traF, and traK), as well as insertion sequences (ISPg3, ISPg5, and ISPg6).   Several other 
transfer (tra) genes were up-regulated but fell below the two-fold threshold.  Numerous 
genes involved in host-pathogen interactions and virulence were also up-regulated such 
as proteases (tpr, trpT, and PG0317), two putative lipoproteins required for major 
fimbriae assembly, and the major 61 and 63kDa surface antigens as well as other cell 
surface polypeptides. 
Of the 46 genes suppressed by CSE exposure, many encoded hypothetical 
proteins whose functions are unknown.  However, two genes were located within the 
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capsular synthesis locus; capK, PG0111 (polysaccharide synthesis gene), and PG0108 
(polysaccharide transport protein).  Additionally, two other capsular synthesis genes were 
also down-regulated upon CSE exposure but fell just below the two-fold limit.  hmuR, a 
tonB-dependent hemoglobin receptor was also down-regulated  as well as fimS, a sensor 
histidine kinase which is believed to be involved in regulating the expression of the major 
and minor fimbrial operons. 
In addition to microarray analysis, a cellular membrane fragment was analyzed by 
SDS gel electrophoresis, which after analysis revealed overexpression of three bands that 
were identified as RagA, RagB, and a putative lipoprotein (PG1079) that is believed to be 
co-expressed with the minor fimbrial antigen. 
It was concluded that the a number of the genes differently regulated by CSE 
exposure are associated with aspects of P. gingivalis virulence such as fimbrial and 
capsular operons, transcriptional regulators, transport proteins, proteases and cell capsule 
proteins as well as up-regulation of several insertion sequence (IS) elements induced by 
CSE promote genetic rearrangements.  It is believed that the genomic response to CSE 
exposure may partially explain the reduced inflammatory potential and altered host-
pathogen interaction of P. gingivalis exhibited in smokers with periodontal disease. 
 
P. gingivalis Virulence 
The previous section described how P. gingivalis adapts to tobacco-induced stress 
by altering the expression of several genes and outer membrane proteins involved in 
virulence, which may serve to lower its inflammatory potential while increasing its 
virulence. The microarray study revealed that CSE induced proteolytic activity, which 
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may contribute to increased virulence.  Also, major fimbrial genes (PG2133, PG2134) 
were induced, while several genes associated with capsular biosynthesis (capK, wecC, 
PG0117, PG0118) were suppressed [115,126].  
P. gingivalis colonization of the oral cavity is dependent upon its interaction with 
other plaque bacteria, including Streptococcus gordonii [119,124].  Another study by 
Bagaitkar et al., 2011 hypothesized that cigarette smoke promoted P. gingivalis-S. 
gordonii biofilm formation in a FimA-dependent manner. The previous microarray 
analysis revealed while major fimbriae expression was significantly increased, minor 
fimbriae function was unaffected [115].  Experimental evidence revealed that P. 
gingivalis biofilms grown in the presence of CSE exhibited a significantly lower pro-
inflammatory capacity (TNF, IL-6) and bound more strongly to immobilized rGAPDH, 
the cognate FimA ligand on S. gordonii, than control biofilms in a dose-dependent 
manner. Nevertheless, a peptide representing the minor fimbrial binding site on S. 
gordonii, (SspB), completely inhibited dual species biofilm formation. Investigators 
concluded that CSE likely augments P. gingivalis biofilm formation by increasing major 
fimbrial avidity, which, in turn, supports initial interspecies interactions and promotes 
subsequent high affinity Mfa1-SspB interactions driving biofilm growth. CSE induction 
of P. gingivalis biofilms of limited pro-inflammatory potential may explain the increased 
persistence of this pathogen in smokers [124].  Additionally, evidence suggests P. 
gingivalis capsule production decreases ability of biofilm growth [125].  P. gingivalis 
capsular biosynthesis genes (capK, wecC, PG0117, PG0118) were suppressed [115,126], 
which may also serve to help promote P. gingivalis biofilm growth and proliferation.  
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Lipid A heterogeneity of P. gingivalis lipopolysaccharides (LPS) are also 
implicated in P. gingivalis virulence and inflammatory potential [128].  Evidence 
suggests tobacco smoke has the ability to induce alteration in the Lipid A region of P. 
gingivalis LPS reducing inflammatory potential, therefore increasing virulence [127].  
 A study by Buduneli et al. [127] analyzed fatty acid profiles of periodontal 
bacteria from salivary samples from individuals with and without periodontal disease, 
with a subset of active smokers and non-smokers in each group.  It was revealed that the 
acyl chain length of 3-OH fatty acids attached to the lipid A portion of bacterial LPS 
significantly affects inflammatory response in periodontal bacteria.  Short straight-
chained fatty acids (12-14 carbons in length) had the highest potency in instigating an 
inflammatory response, while longer chains (17 carbons in length) showed significantly 
reduced inflammatory potential.  
A study by Herath et al. [129] also gives evidence that structural lipid A 
heterogeneity in P. gingivalis can reduce its inflammatory potential by examining how P. 
gingivalis LPS lipid A heterogeneity differentially modulates the expression of IL-6 and 
IL-8 in human gingival fibroblasts (HGFs).  HGFs were stimulated with 
P. gingivalis tetra-acylated LPS (1435/1449) and penta-acylated LPS (1690) in a dose 
dependent manner. Results indicated that penta-acylated LPS (1690) significantly up-
regulated the mRNA and protein expression of IL-6 and IL-8, whereas the tetra-acylated 
LPS (1435/1449) did not induce significant host response. Because tobacco smoke has 
the ability to alter acyl chain length [127], it can be easily hypothesized that tobacco 
smoke may also influence P. gingivalis LPS lipid A acylation. P. gingivalis LPS lipid 
A heterogeneity may differentially modulate pro-inflammatory cytokine expression, 
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allowing P. gingivalis subvert immune surveillance contributing to increased virulence 
and periodontal pathogenesis. [85,87,129]. 
 
Tobacco Smoke, P. gingivalis, and Periodontal Disease 
 
Our main objective in this thesis was to identify potential genomic instability and 
genetic rearrangements and alterations induced by cigarette smoke extract (CSE) in the 
periodontal and systemic pathogen Porphyromonas gingivalis, which is a keystone 
pathogen and strongly implicated in periodontal disease pathogenesis 
[112,113,116,120,123].  CSE is an environmental stressor to P. gingivalis and upon 
exposure, up-regulated 58 P. gingivalis genes [115]. Of these, groups of genes encoding 
proteins involved in DNA translocation, replication and repair such as ruvC  (PG1324), a 
putative integrase (PG0817), and radC (PG0894), as well as members of the tra family of 
proteins, traE (PG1483), traF (PG1482), and traK (PG1478) were up-regulated, which 
may indicate genomic instability and genetic alterations and repairs upon CSE exposure.  
Of particular interest to us was the up-regulation of insertion sequences (IS) ISPg3 
(PG0299), ISPg5 (PG0943), and ISPg6 (PG1061).  
Insertion sequences are relatively short sequences of DNA between 800 and 2,500 
base pairs long and can greatly contribute to genomic variability and evolution.  IS 
elements contain at least one open reading frame, which encodes a transposase enzyme 
that allows the IS element to move throughout the genome in either a cut-and-paste or 
copy-and-paste fashion.  
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Study Hypothesis 
 
Our main hypothesis is that exposure of cigarette smoke (CSE) would induce 
mutations and allelic variance in P. gingivalis.  If so, we would establish that tobacco 
smoke may promote bacterial evolution with the potential for the emergence of more 
virulent clinical strains which may infect smokers and non-smokers alike.
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CHAPTER TWO: MATERIALS AND METHODS 
 
 
Materials 
 
	  P. gingivalis W83 was purchased from the American Type Culture Collection 
(Manassas, VA); P. gingivalis growth medium - Gifu Anaerobic Medium (GAM), was 
bought from Nissui Pharmaceutical (Tokyo, Japan). 3R4F standard reference cigarettes 
were obtained from the Kentucky Tobacco Research and Development Center 
(Lexington, KY).  ). The Wizard genomic DNA purification kit came from Promega 
(Madison, WI). Primers were ordered from Bio-Synthesis, Inc. (Lewisville, TX).
 
Bacterial Culture and In Vitro Modeling of Tobacco Exposure 
 
Porphyromonas gingivalis W83 was maintained as frozen stock culture. P. 
gingivalis was then grown in GAM or GAM conditioned media with cigarette smoke 
extract (GAM-CSE) under anaerobic conditions (80% N2, 10% H2, 10% CO2) at 37°C in 
a Coy Laboratories (Grass Lake Charter Township, MI) anaerobic chamber.  P. gingivalis 
cells were harvested at mid- to late-exponential phase (OD600 = 1.0, corresponding to 109 
cells per ml). GAM-CSE media was prepared using 3R4F reference cigarettes.  Cigarette 
smoke was drawn through 50mL of GAM using a syringe, and a three-way stopcock, in 
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35mL drags every 20 seconds as described previously [115]. One cigarette was smoked 
per 50mL of media.  The CSE-conditioned medium was filtered (0.22mm) and diluted to 
a concentration of 4000 ng ml nicotine. Nicotine content was determined by gas–liquid 
chromatography as described previously [133], and adjusted to pH 7.2. Upon reaching an 
OD600 of 1.0, P. gingivalis was sub-cultured into fresh GAM-CSE until 50 passages were 
completed. 
 
Isolation of Genomic DNA 
Genomic DNA was isolated from 1.5 ml bacterial culture (OD600 = 1.0, 
approximately 109cells/ml) after 50 passages in GAM-CSE with the Wizard genomic 
DNA purification kit according to manufacturer’s instructions. 
 
Whole Genome Sequencing 
 
 The complete genomic sequences of both control and CSE-exposed P. gingivalis 
(after 50 passages in GAM or GAM-CSE) were obtained using the Illumina HiSeq2000 
sequencing platform with paired end sequencing and a read length of 100 base pairs.  The 
paired end reads from the control and CSE treated samples were mapped, respectively, 
using the BWA program ([http://bio-bwa.sourceforge.net/] version 0.6.1) to the P. 
gingivalis W83 assembly NC_002950.2 
(http://www.ncbi.nlm.nih.gov/nuccore/NC_002950.2).  The mapping process consisted 
first of running BWA program on each fastq file, followed by a run of sampe to create a 
SAM file from the R1 and R2 read pairs.  The resulting SAM file was converted to a 
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BAM file and sorted using Samtools ([http://samtools.sourceforge.net/] version 0.1.18). 
PCR duplicates were identified in each BAM file and removed using Picard Tools 
([http://picard.sourceforge.net/] version 1.65) Mark Duplicates.   Insertion and deletion 
(Indel) targets were identified using the Genome Analysis Toolkit (GATK) 
([http://www.broadinstitute.org/gatk/] version 1.5) Realigner Target Creator.  These 
targets were then fed into GATK Indel Realigner.  These cleaned reads were then run 
through Samtools mpileup to create pileup files, which were used to derive absolute allele 
counts at each position for the respective BAM files.  The de-duplicated, realigned BAM 
files were loaded into the Intrepid Bioinformatics data management system, and may be 
viewed in their entirety at: 
 
Control: 
http://server1.intrepidbio.com/FeatureBrowser/ngsdatasetrecord/record?ngsrecord=64411
08798 
 
 
CSE: 
http://server1.intrepidbio.com/FeatureBrowser/ngsdatasetrecord/record?ngsrecord=64411
08803 
 
 
Confirmation of Point Mutations 
 
Confirmation (i) – Visual Inspection 
 Each statistically significant identified mutation was viewed in Integrative 
Genomics Viewer (IGV) [intrepidbio.com] to view the position of the mutations within 
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the read as well as the read lengths to determine possible sequencing errors and 
misalignments. 
 
Confirmation (ii) – BLASTn 
 A nucleotide BLAST search [http://blast.ncbi.nlm.nih.gov/] was also conducted at 
for each significant mutation read sequence to control for alignment errors. 
 
Confirmation (iii) – Allele Specific PCR 
The presence of the variant alleles were also confirmed using allele specific PCR, 
when possible. PCR reactions were performed in triplicates as described by Calero et al. 
[136] using 50ng of template DNA, 0.3µM of each Primer and 12.5µl of RT2 SYBR 
Green ROX Mastermix on an Applied Biosystems 7500 Real-Time PCR System 
(Invitrogen, Carlsbad, CA) under following conditions: 2min at 50˚C, 10min at 95˚C, 40 
cycles of 15sec at 95˚C and 1min at 55˚C, with data collection during the 55˚C step. A 
dissociation stage followed each run to allow for the analysis of melting curves. Changes 
in cycle threshold (Ct) values were calculated by subtracting the mean Ct value of the 
variant alleles from the mean Ct value of the control alleles (Ctvariant – Ctcontrol = ΔCt). 
 
Statistical Analyses  
 
Mutations 
Sequence variants were screened for statistical analysis using the genome analysis 
toolkit (GATK), to identify sequence variants in the CSE and control population samples.  
  35 
Allele and insertion / deletion counts from these 190 sequence variants were analyzed for 
differences in allele or insertion / deletion frequency between control and CSE samples 
using chi-squared tests of the 2x2 table consisting of the two most common alleles or the 
most common allele along with insertion / deletion count.  Corresponding p-values were 
adjusted for multiple comparisons using the Benjamini-Hochberg approach [134], which 
controls the false-discovery rate.   
 
Allele frequency/Read Variance 
The mean- and median- percent variation from the reference allele 
(http://www.ncbi.nlm.nih.gov/nuccore/NC_002950.2) (referred to as the ‘minor allele 
frequency’) was calculated across all nucleotides separately for both CSE and control 
samples genomes.  Simulated allele counts were generated at each position using an 
averaged minor allele frequency between CSE and control samples.  Each nucleotide was 
treated as independent.  Minor allele frequencies were then averaged across the genome 
for each of these simulated CSE and control genome counts.  This was repeated 1000 
times, and then this distribution of differences between CSE and control compared to the 
true differences in both mean and median minor allele frequencies.  An empirical p-value 
was determined by the proportion of values from the null distribution that are greater than 
the observed (original) difference. 
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CHAPTER THREE:  CSE EXPOSURE PROMOTES GENOMIC INSTABILITY 
AND BACTERIAL EVOLUTION. 
 
Results 
 
CSE Induces Point Mutations in P. gingivalis 
 
 Complete genomic sequences of control and CSE-exposed P. gingivalis (after 50 
passages in GAM-CSE) were obtained using the Illumina HiSeq2000 sequencing 
platform, using paired end sequencing with reads approximately 100 base-pairs long. It is 
important to acknowledge that the final whole genome sequence for this experiment is 
representative of a composite genome of all CSE-induced alterations to P. gingivalis 
extant after 50 passages.  Considering, after prolonged passaging in CSE, there were 
likely to be multiple mutations induced in individual replicating bacterial cells. Naturally, 
many of these mutations will have been further propagated. Therefore, the final microbial 
population is likely to be composed of a variety of chromosomal sequences and should 
not be considered a single entity.  
Keeping this in mind, CSE proved to be an environmental stressor capable of 
inducing 22 (p<0.05) point mutations as presented in Table 1: 
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TABLE 1: Statistically Significant Mutations 
 
Position p-value 
2282335 0 
2068758 7.38E-99 
1463982 1.04E-92 
2307777 1.06E-79 
1707468 3.76E-42 
2068683 5.04E-41 
2068587 1.63E-32 
1371743 1.00E-23 
2068514 4.78E-16 
275989 1.99E-15 
1963511 3.95E-10 
2068717 5.81E-10 
2068645 3.24E-09 
2068720 1.26E-08 
1963452 2.29E-06 
1963451 4.39E-06 
2068718 0.001 
1963860 0.001 
1963868 0.008 
599501 0.014 
2068540 0.017 
2049674 0.034 
 
 
Confirmation of Point Mutations 
 We were able to confirm 17/22 (77%) mutations from Table 1 using: (i) - visual 
inspection; (ii) – BLASTn; and (iii) – allele-specific PCR [described previously in 
Methods]. Due to several variants being located within highly repetitive DNA sequence 
patterns - which does not allow for effective primer design - allele-specific PCR was only 
employed for three positions as shown in Table 2 and Table 3.   
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Table 2: Primer design for allele-specific PCR 
Position Sequence Forward Primer  
(5’-3’) 
Sequence Reverse Primer (5’-3’) 
1707468 CATGCT CATCGGTATTCTTG TATTTTTCGTGGGGCAAGATG 
 
CTCCCTATCGTATCTCTCTAG 
(Deletion) 
2282335 TATGCTGCTTTCTACTGCCCA GTGAGGAACGCCACGCCT 
 
GTGAGGAACGCCACGCCC  
(C Allele) 
2307777 CTATCCTGACTTTGTCGTCGG AGTCGAAGAGCTGCTTTTTTTC 
 
AGTCGAAGAGCTGCTTTTTTC 
(Deletion) 
 
Table 3: Allele-specific real-time PCR ΔCt Values 
 GAM control culture 50th passage in CSE  
Position Ct Regular 
Allele 
Ct Variant 
Allele 
ΔCt Ct Regular 
Allele 
Ct Variant 
Allele 
ΔCt 
1707468 11.91 24.60 12.69 12.65 12.26 -0.39 
2282335 11.89 14.72 2.83 15.83 11.24 -4.59 
2307777 17.08 16.10 -0.98 18.15 14.45 -3.7 
 
The negative CSE ΔCt values in Table 3 represent a higher amount of variant 
allele present than the reference allele and control culteres as given by, (Ctvariant – 
Ctcontrol = ΔCt). values The 17 mutations spanned across the entire genome and were 
comprised of four deletions, three insertions, and ten Single Nucleotide Polymorphisms 
(SNPs) accounting for 18%, 23%, and 59%, respectively as shown in Tables 4-6 below. 
TABLE 4: Deletions 
Position Gene Function Deletion 
2307777 PG2200 hypothetical protein T 
1707468 IGR -- ATCTTGCCCCACGAAAAATAGA
TTAAACTCATTCTCGGAACGCA
CTCTAAATCAA 
2068587 IGR -- TACGGAC 
2068514 IGR -- TACGGAC 
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TABLE 5: Insertions 
Position Gene Function Insertion 
2068717 IGR -- G 
2068645 IGR -- AGTAAT 
2068540 IGR -- CAG 
 
 
 
TABLE 6: Single Nucleotide Polymorphisms (SNPs) 
Position Gene Function Control Mutation 
2282335 PG2174 hypothetical protein T C 
2068758 IGR -- T A 
2068683 IGR -- A C 
1963511 PG1864 leucine-rich protein A T 
2068720 IGR -- A T 
1963452 PG1864 leucine-rich protein T A 
1963451 PG1864 leucine-rich protein G T 
2068718 IGR -- C A 
1963860 PG1864 leucine-rich protein T C 
1963868 PG1864 leucine-rich protein T G 
 
 Five of the seven gene-based point mutations (71%) were SNPs located within 
PG1864, a leucine-rich protein.  The other two gene-based mutations were located 
individually within PG2174 (SNP) and PG2200 (Deletion) both of which are hypothetical 
proteins. 
 
CSE-exposure increases minor allele frequency (read variance) in P. gingivalis 
The mean- and median- percent variation from the major allele was calculated 
across all nucleotides separately for both CSE and control samples genomes.  Simulated 
allele counts were generated at each position using an averaged minor allele frequency 
between CSE and control samples.  Each nucleotide was treated as independent.  Minor 
allele frequencies were then averaged across the genome for each of these simulated CSE 
and control genome counts.  This was repeated 1000 times, and then this distribution of 
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differences between CSE and control compared to the true differences in both mean and 
median minor allele frequencies.  The results are as shown in Table 7 below as 
proportions, rather than percentages.   
TABLE 7:  WGS Read Allele Variance 
 Mean Median 
Control 0.00266653 0.00147384 
CSE 0.00271093 0.00149813 
 
CSE samples had slightly higher mean and median variance than control samples, 
which was determined to be significant (p < 0.001) in comparison to control samples.   
 
Discussion 
 
 Cigarette smoking increases vulnerability to P. gingivalis infection and increases 
susceptibility to periodontitis, but reduces clinical signs of overt inflammation. The 
underlying mechanisms involved in this clinical conundrum are still being investigated 
and remain to be determined.  However, it has been hypothesized that cigarette smoke 
suppresses host immunity while in contributing to increased bacterial virulence [17]. 
Several studies have already implicated tobacco smoke in increasing the virulence of P. 
gingivalis.  We know from previous data that genetic expression of P. gingivalis is 
differentially regulated upon exposure to CSE. Major fimbrial genes (PG2133, PG2134) 
were induced, while several genes associated with capsular biosynthesis (capK, wecC, 
PG0117, PG0118) were suppressed [115,126]. Evidence also suggests tobacco smoke has 
the ability to induce alterations to the Lipid A region of P. gingivalis LPS reducing 
inflammatory potential, therefore increasing virulence and promoting proliferation [127].   
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 It has also been shown that tobacco smoke contains several toxic chemicals as 
well as the capacity to generate reactive oxygen species [5-7] which have damaging 
effects on bacterial DNA [90-92].  The previous microarray study [115] also indicated the 
up-regulation of several genes encoding proteins involved in DNA replication, 
translocation, and repair.   
Our experimental results show that P. gingivalis exposure to CSE promotes 
genomic instability by inducing 17 point mutations as well as inducing statistically 
significant (p<0.001) read variance. After only 50 passages of exposure over a 23.5Mb 
genome, our results imply considerable potential for genetic variance in P. gingivalis 
induced by CSE, which is in line with our hypothesis. 
Given the relatively small number of significant point mutations across the entire 
P. gingivalis genome, striking clusters were noted in certain regions.  For example, nine 
of the observed variants occur in the region between 2068514 and 2068758 (IGR-[2]**), 
while five occurred in the region between 1963451 and 1963868 (PG1864*) as shown in 
Figure 2 [135] below.   
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 As for the limitations of the whole genome sequencing used in this project 
(Illumina HiSeq2000), the short read technology (read length of approximately 100 
bases) isn't optimal for characterizing regions with tandem repeats.  Complementary, 
longer read technologies such as the ionTorrent, ionProton, or better still, PacBio will 
remove much of the ambiguity, and as a result will significantly improve our ability to 
characterize these regions.   
We also did not explore whether CSE exposure additionally causes epigenetic 
changes, altering the activity of DNA by chemical modifications of DNA or histone 
proteins, for example by affecting methyl or acetyl adducts. Such information would 
provide additional valuable information and warrants future investigation to clarify the 
influence of cigarette smoke on the epigenetic level. 
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In summary, smokers are more prone to infection with P. gingivalis and to 
develop periodontitis, yet exhibit reduced clinical inflammation.  Our experimental 
results gives further evidence to that cigarette smoke is an important driving force for 
bacterial evolution. We have found that Porphyromonas gingivalis’ response to CSE 
exposure results in genome wide allele variance and point mutations. These results may 
explain in part the effects tobacco smoke in altering the virulence of this key periodontal 
pathogen that may contribute to the emergence of more virulent strains, which may infect 
smokers and non-smokers alike.
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Research Experience 
 
Virology Study (Undergrad-UK)  
It was hypothesized that Human Herpes Virus (HHV) promotes and increases the 
risk of periodontal infections.  Based on conflicting data, the goal of this research project 
was to study the potential role that HHVs play in periodontal disease using an 
experimental rat model.  
To examine this question my mentor and I studied the influence of rat 
cytomegalovirus (RCMV), on the development of periodontitis using a rat model of 
periodontal disease. RCMV is genetically related to human cytomegalovirus, one of the 
most common types of herpes virus found at sites of periodontal infection. Our research 
investigated how the time-course of acquisition of RCMV infection influenced the 
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progression of periodontal disease in rats colonized with a human periodontitis bacterial 
strain, Porphyromonas gingivalis. 
 Two experiments were designed to investigate potential interactions between 
these agents in promoting periodontitis in immunocompetent (Study-1) and 
immunosuppressed rats (Study-2). In these studies, 4-5 week-old rats were placed in and 
control and experimental treatment groups and inoculated with RCMV, P. gingivalis, or 
both agents at varying time-points. The RCMV was given by intraperitoneal injection and 
the P. gingivalis by oral gavage. Blood samples for determination of immune responses 
were collected at the start of the experiment and at approximate monthly intervals during 
the 4-month time-course of the experiment. At these times anesthetic was administered to 
allow for the collection of dental plaque samples to characterize the inflammatory profile 
of the rat periodontal tissues and to determine the persistence of P. gingivalis and/or 
RCMV in the oral cavity. At the end of each experiment the rats will be euthanatized by 
inhalation of CO2 gas. Gingival (periodontal) tissues will be excised for histological and 
molecular analysis and the mandibles and maxillary bones removed for radiographic 
evaluation of alveolar bone loss related to periodontal disease.  
 Rats in the second study, modeling periodontal disease in immunosuppressed 
hosts (e.g. cancer, AIDS, or organ transplant patients), were treated with whole body 
irradiation or immunosuppressive drugs to impair their immune system. The rats were 
divided into similar treatment groups and diagnostically sampled like rats in Study-1.  
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Telomere Study (Undergrad-UK)  
 In this independent research project I hypothesized the function of spatially 
clustered telomere end genes of an Aspergillus nidulans (fungus) chromosome served a 
functionally common purpose based on preliminary data which, indicated they were 
involved with metabolic/growth function.  To test this theory I used software programs 
and bioinformatics databases such as Broad Institute, BLAST, and Vector NTI to 
sequence the genes in question, compare them against phylotypically related species to 
try and determine a predicted function for each gene.  From these sequences, primers for 
DNA polymerase reactions were designed to construct gene knockouts.  The knockouts 
were then used to test the functionality of each of the 6 identified genes I was examining, 
independently and together to try and determine their individual function and a possible 
hypothesized common function.  Effects of gene knockouts were measured 
morphologically compared to control A. nidulans colonies.   
 
Future Academic Plans 
 
After completing this Master’s Degree, I will be attending the University of 
Kentucky College of Dentistry beginning the fall 2013 semester and graduate with the 
Doctor of Medical Dentistry (DMD) Class of 2017. 
